Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Debt / NOTE 5.250%12/0
-
Market price (% of par)
-
107.49%
-
Total 13F principal
-
$88,239,000
-
Principal change
-
+$30,000
-
Total reported market value
-
$95,335,801
-
Number of holders
-
11
-
Value change
-
+$253,292
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 as of Q2 2019
As of 30 Jun 2019,
LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 was held by
11 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$88,239,000
in principal (par value) of the bond.
The largest 10 bondholders included
CITADEL ADVISORS LLC, Polygon Management Ltd., LAZARD ASSET MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, UBS ASSET MANAGEMENT AMERICAS INC, DEUTSCHE BANK AG\, DeepCurrents Investment Group LLC, Verition Fund Management LLC, JPMORGAN CHASE & CO, and MACKAY SHIELDS LLC.
This page lists
11
institutional bondholders reporting positions
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.